chang recommend
downgrad in-lin -- webinar
et
stock gener phenomen perform sinc
heel mani thing go right
management deliv long term commit op
margin expans bp
capit return sharehold via extens buy-back
look back past year major driver
top-line beat delay biosimilar competit
base biz vs conserv consensu model
sit earli biosimilar inde launch
fare well
importantli court decis biggest drug
enbrel immin biosimilar alreadi
tent approv unlik conserv consensu
current consensu bake biosimilar
enbrel till meanwhil district court decis
due day sandoz express desir
potenti launch heel district court
decis also appeal process wrap
jan regardless base analysi case
doubl patent real concern
ahead upcom court decis revisit model
lot detail get dcf valu
scenario bake
risk see imag result move
acknowledg retain pipelin option
balanc year bodi languag upcom
kra ph data posit put ph data
long-act bcma year well also
tvec keytruda ph melanoma could read although
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect object
report investor consid report singl factor make invest decis
data qualiti comp vs ipi nivo ph
go upsid valuat scenario deep
host webinar et go
thought lot detail slide
link webinar
price target combin cash flow earn estim deriv valuat methodolog use discount rate
function cost equiti cost debt termin growth rate estim use deriv futur cash flow
regulatori commerci legal includ potenti delay pipelin develop gener entri establish product
chang drug price chang tax law loss patent exclus unfavour litig outcom and/or poor
articl articl
time dissemin januari
analyst umer raffat primarili respons prepar research report attest follow view opinion
render research report reflect person view subject compani issuer part research
analyst compens directli relat specif recommend view research report
report approv and/or distribut evercor group llc evercor group licens broker-deal regul
industri regulatori author finra intern strategi invest group uk limit lsi uk authoris
regul unit kingdom financi conduct author institut sale trade research busi evercor group
lsi uk collect oper global market brand name evercor lsi evercor lsi evercor group lsi uk
subsidiari evercor partner inc evercor partner trademark logo servic mark shown report regist
trademark evercor partner
analyst associ respons prepar report receiv compens base variou factor includ evercor partner
total revenu portion gener affili invest bank transact evercor lsi seek updat research
appropri variou regul may prevent happen certain instanc asid certain industri report publish
period basi larg major report publish irregular interv appropri analyst judgment
evercor lsi gener prohibit analyst associ member household maintain financi interest secur
compani analyst area coverag except polici requir specif approv member complianc
depart ownership subject complianc applic regul disclosur evercor lsi also prohibit analyst associ
